Anxiety, Anxiety Chronic, Assertiveness, Depression - Major Depressive Disorder, Functional Outcome, Obsessive Compulsive Disorders, Recovery
Conditions
Keywords
Cystic Fibrosis, Group cognitive behavioral psychotherapy
Brief summary
An online group cognitive behavioral psychotherapeutic program will be offered to patients with cystic fibrosis and to caregivers by the Hellenic Cystic Fibrosis Association. These 2 above therapy groups will be compared with control groups in a randomized controlled trial
Detailed description
A therapy group of patients with cystic fibrosis, who participate on the online group cognitive behavioral psychotherapeutic program will be compared with a control group of patients with cystic fibrosis, who participate in an online group supportive psychotherapeutic program. Both of the groups participate on 13 sessions once a week. A therapy group of caregivers, who participate on the online group cognitive behavioral psychotherapeutic program will be compared with a control group of caregivers, who participate in an online group supportive psychotherapeutic program. Both of the groups participate on 13 sessions once a week.
Interventions
BEHAVIORALGroup A An online group cognitive behavioral psychotherapy in 13 sessions via Zoom
An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy Group A, to patients with cystic fibrosis
BEHAVIORALGroup B An online group supportive psychotherapy in 13 sessions via Zoom
An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control group Group B, to patients with cystic fibrosis
BEHAVIORALGroup C An online group cognitive behavioral psychotherapy in 13 sessions via Zoom
An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy group C, to caregivers of patients with cystic fibrosis
BEHAVIORALGroup D An online group supportive psychotherapy in 13 sessions via Zoom
An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control Group D, to caregivers of patients with cystic fibrosis
Sponsors
Rakitzi, Stavroula
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Intervention model description
A therapy group with patients with cystic fibrosis will be compared with a control group with patients with cystic fibrosis. A therapy group with caregivers will be compared with a control group with cqaregivers
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Age 18-70 * Members of the Hellenic Cystic Fibrosis Association * Willingness to participate on 13 sessions via Zoom
Exclusion criteria
* Age over 70 * Not members of the Hellenic Cystic Fibrosis Association * Not able to participate on 13 sessions via Zoom
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| SCL-90-R | Preintervention | It evaluates psychopathology. T\>60 means psychopathology. Low scores better |
| SRSDA | Preintervention | It measures Depression. Minimum 0 Maximum over 14. Low scores better |
| U Uncertainty questionnaire | Preintervention | It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9) |
| Hamilton Depression Scale | Preintervention | It measures depression. Minimum 0, maximum 23. Low scores better. |
| WHODAS total | Preintervention | It measures functional outcome. Minimum 0, maximum 100. low scores better. |
| RAS-DS total | Preintervention | Recovery. It measures recovery. Minimum 0, maximum 152. High scores better. |
Countries
Greece
Contacts
CONTACTDr. Stavroula Rakitzi, PhD
CONTACTMrs Anna Spinou, President of the Hellenic Cystic Fibrosis Association, Msc
STUDY_CHAIRDr. Stavroula Rakitzi
Private Practice
Outcome results
None listed